To the Editor:

Rhinovirus (RV) and human bocavirus 1 (HBoV1) are common causes of respiratory tract infections in early childhood.[@bib1] While RV is an RNA virus and causes recurrent infections with new strains, HBoV1 is a DNA virus that may cause prolonged shedding and is mostly found simultaneously with other respiratory viruses.[@bib1] Both viruses are associated with early wheezing: RV has been detected in approximately 20% to 40% of the cases, acute HBoV1 infection has been serodiagnosed in 19% of the cases, and RV-HBoV1 coinfection has been detected in 6% of the cases.[@bib1] Unlike RV wheeze,[@bib2] HBoV1 wheeze has not been linked with an increased risk of asthma in early childhood. The asthma and atopy in children are closely interrelated with increased T~H~2-type cells, and decreased type I/II/III interferon (IFN) responses and susceptibility to RV infections.[@bib3] Less is known about HBoV1, but HBoV1 bronchiolitis has been associated with balanced T~H~1/T~H~2-type response in nasopharyngeal mucosa.[@bib4] Whether these cytokine responses reflect the immunity of the host or the species of the virus is unclear. Interestingly, cloned HBoV1 has inhibited Sendai virus--induced IFN production *in vitro*, suggesting that it may also affect the host responses against other viruses *in vivo*.[@bib5] However, *in vivo* data of virus interference by respiratory virus in humans are lacking.

The objective of this study was to compare the systemic T~H~1-type, T~H~2-type, IL-10, and proinflammatory cytokine profiles in young children with sole RV- or sole HBoV1-associated wheezing. Moreover, we wanted to investigate whether codetection of RV and HBoV1 would be associated with a different cytokine response than would detection of either virus alone.

This study is a substudy of the larger Vinku study including children hospitalized for acute wheezing in the Department of Pediatrics, Turku University Hospital, Turku, Finland, during the period from September 2000 through May 2002. (For study flow chart, see [Fig E1](#dfig1){ref-type="graphic"} in this article\'s Online Repository at [www.jacionline.org](http://www.jacionline.org){#intref0010}.)[@bib2], [@bib6] The present study included all 3- to 35-month-old children of the cohort who had their first or second wheezy episode and had sole RV (n = 18), sole HBoV1 (n = 13), or combined RV-HBoV1 infection without evidence of other viruses (n = 17). The study protocol was approved by the Ethics Committee of the Turku University Hospital, and informed consent was obtained from the guardian before commencing the study.

At hospital admission, 16 respiratory viruses were tested. Virus culture was done for adenovirus, enteroviruses, RV, influenza A and B viruses, human metapneumovirus, parainfluenza virus types 1 to 3, and respiratory syncytial virus. Viral antigens were detected for adenovirus, influenza A and B viruses, and respiratory syncytial virus. Levels of specific IgG antibodies were measured from paired serum samples for adenovirus, enteroviruses, influenza A and B viruses, and parainfluenza virus 1 to 4. PCR was used for the detection of adenovirus, coronaviruses (229E, OC43, NL63, and HKU1), enteroviruses, HBoV1, RV (including RV-C species), influenza A and B viruses, metapneumovirus, respiratory syncytial virus, and parainfluenza virus 1 to 4. All acute HBoV1 infections were serologically confirmed.[@bib6] Serum taken at study entry was analyzed for the following cytokines by using the Human Cytokine LINCO *plex* Kit (Millipore Corporation, Billerica, Mass; sensitivities for each cytokine are shown in [Table E1](#tblE1){ref-type="table"} in this article\'s Online Repository at [www.jacionline.org](http://www.jacionline.org){#intref0015}): GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, and TNF-α.[@bib7] Children were followed up for 7 years, and the time to recurrent wheezing was assessed as previously defined.[@bib2]

The normality of data distribution was tested by using the Kolmogorov-Smirnov test. Because of the skewness of the data, cytokine levels were log~10~ transformed. For other statistics, *t* test, Mann-Whitney U test, χ^2^ test, 1-way ANOVA, Kruskal-Wallis test, Log-rank test, and Cox proportional hazard ratio test were used when appropriate (PASW 18.0 software; SPSS, Inc, Chicago, Ill).

The mean age of the whole cohort was 1.6 years with slight male predominance (69%). Sensitization was detected in 35% of the patients (allergen-specific IgE \> 0.35 kU/L for common allergens, Phadiatop Combi; Phadia, Uppsala, Sweden), 67% of the children had their first wheezy episode, and parental asthma was reported in 17% of the children. Long-term controller medication for recurrent wheezing was initiated for 61% of the children during the follow-up, all within the first 2 years. Patient characteristics did not differ between the virus groups (see [Table E2](#tblE2){ref-type="table"} in this article\'s Online Repository at [www.jacionline.org](http://www.jacionline.org){#intref0020}).

Wheezing children with RV had higher proinflammatory (IL-1β, IL-7, and IL-8), T~H~ 1-type (IL-2), and T~H~ 2-type (IL-4 and IL-13) responses than did those with HBoV1 ([Fig 1](#fig1){ref-type="fig"} ). Interestingly, no differences in the cytokine levels were found between the HBoV1 and RV-HBoV1 coinfection groups, and the cytokine responses seen in the RV group were generally lower in the RV-HBoV1 group ([Fig 1](#fig1){ref-type="fig"}). While IFN-γ or IL-10 levels did not differ between the study groups, the IL-4/IFN-γ ratio was higher (median \[interquartile range\], RV 4.8 \[1.7-16.0\]; RV-HBoV1 1.4 \[0.1-4.2\]; HBoV1 0.2 \[0.1-0.4\]; overall *P* = .001) and the IL-10/IL-12 ratio was lower (RV 4.1 \[2.3-6.4\]; RV-HBoV1 17.3 \[7.1-29.0\]; HBoV1 30.5 \[6.5-52.7\], respectively; *P* = .007) in the RV group than in the HBoV1 or RV-HBoV1 groups. Otherwise, no differences in cytokine responses were detectable between the virus groups.Fig 1Cytokine responses in wheezing associated with RV, HBoV1, and combined RV-HBoV1 in young children. The data are expressed as median (interquartile range) and analyzed by 1-way ANOVA and Tukey *post hoc* comparison. \**P* \< .05 vs the RV group.

Sensitized children had lower IL-10 and IFN-γ levels and a lower IL-10/IL-12 ratio but a higher IL-4/IFN-γ ratio than did nonsensitized children (*P* \< .05 for both; see [Table E3](#tblE3){ref-type="table"} in this article\'s Online Repository at [www.jacionline.org](http://www.jacionline.org){#intref0025}). On repeating virus group comparisons without sensitized children, all significant differences persisted except for IL-10/IL-12 and IL-4/IFN-γ ratios (data not shown). Wheezing children with RV had a trend to develop recurrent wheezing more often and sooner than did those with RV-HBoV1 or HBoV infection (*P* = .10, [Fig 2](#fig2){ref-type="fig"} ; see also [Table E2](#tblE2){ref-type="table"}).Fig 2Incidence of recurrent wheezing in young children with RV (n = 16), HBoV1 (n = 11) and combined RV-HBoV1 (n = 11)-associated wheezing. The data are expressed as percentage of children with recurrent wheezing after the study entry. Data were analyzed by using the Log-rank test. Overall comparison, *P* = .10; RV vs RV-HBoV1, *P* = .07; RV vs HBoV1, *P* = .11.

Our study shows 2 important findings. First, unlike RV, HBoV1 is not associated with systemic proinflammatory or T~H~ 2-type cytokine responses during acute wheezing. Interestingly, coinfection with RV and HBoV1 resulted in a modified, non--T~H~ 2-type cytokine response. This finding together with previous *in vitro* data[@bib5] suggests that HBoV1 may interfere with RV-induced immune responses. The immunological responses were accompanied by the clinical finding that children with HBoV1 or combined RV-HBoV1 wheeze tended to develop recurrent wheezing later and less often than did those with RV wheeze. Because the severity of RV infections is known to be related to atopic status,[@bib8] understanding the mechanism of HBoV1 infection may open new targets to tackle RV-associated undesired events such as recurrent wheeze and asthma development.[@bib2], [@bib9]

Second, sensitized children had higher IL-4/IFN-γ and lower IL-10/IL-12 ratios in consistence with atopic inflammation. These changes were similar to those reported in RV infection,[@bib3] although we were not able to show a significant link between RV and atopy. These findings fit in a hypothesis that early T~H~2-skewed inflammation exists in RV wheeze before sensitization can be detected.[@bib2] Altogether, our findings suggest that immunological responses in acute wheezing are dependent on both host (atopy-related inflammation) and virus-specific factors and that virus-virus interaction may be of significance in modulating these responses.

Appendix {#appsec1}
========

Fig E1Study flow chart. *ICU*, Intensive care unit. Table E1Sensitivities of the assay (in pg/mL) ([www.millipore.com](http://www.millipore.com){#intref0030})CytokineLowest detectable concentrationNo. of samples below the detection limitIL-1β0.1922 of 47IL-20.388 of 48IL-42.877 of 48IL-50.123 of 47IL-60.790 of 47IL-70.424 of 48IL-80.320 of 48IL-100.410 of 48IL-120.236 of 48IL-134.0612 of 48IFN-γ0.556 of 48GM-CSF0.233 of 48TNF-α0.220 of 48 Table E2Patient characteristicsRV (n = 18)RV-HBoV1 (n = 17)HBoV1 (n = 13)Age (y), mean ± SD1.4 ± 0.61.6 ± 0.91.6 ± 0.7Male13 (72%)11 (65%)9 (64%)Sensitized[∗](#tblE2fnlowast){ref-type="table-fn"}8 (44%)3 (18%)7 (54%) Aeroallergen5 (28%)2 (12%)0 (0%) Food allergen8 (44%)3 (18%)7 (54%)Eczema7 (39%)5 (29%)5 (36%)Parental Asthma2 (11%)2 (12%)3 (21%) Allergy10 (56%)10 (59%)11 (79%) Smoking10 (56%)3 (18%)7 (50%)First wheeze10 (56%)12 (71%)10 (77%)Recurrent wheezing[†](#tblE2fndagger){ref-type="table-fn"}12 of 16 (75%)5 of 11 (46%)5 of 11 (46%)[^1][^2][^3] Table E3Cytokine levels in sensitized vs nonsensitized childrenSensitized[∗](#tblE3fnlowast){ref-type="table-fn"}IQRNonsensitizedIQR*P* valueIL-1β0.60.0-1.70.00.0-0.9*.29*IL-21.20.1-9.51.20.3-7.7.93IL-4111.99.8-211.022.53.9-107.2.62IL-54.01.7-13.85.82.1-15.6.53IL-624.99.5-53.318.010.6-32.7.54IL-710.96.6-20.910.36.4-16.4.99IL-812.58.9-19.610.08.1-15.1.93*IL-1028.621.8-46.969.329.7-108.3.004*IL-122.60.0-11.73.20.9-7.9.80IL-1338.69.5-92.083.0-54.8.25*IFN-γ9.10.0-18.024.25.6-79.1.02*GM-CSF6.52.5-15.23.52.1-9.6.28TNF-α13.410.6-16.612.110.2-16.3.85*IL-4/IFN-γ3.20.8-12.30.50.1-3.4.01IL-10/IL-125.42.4-8.124.16.0-45.7.03*[^4][^5][^6]
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[^1]: Values are expressed as mean ± SD or n (%). The overall differences between virus groups were tested by using the chi-square test: all *P* \> .10.

[^2]: Allergen-specific IgE \> 0.35 kU/L.

[^3]: After study entry, *P* = .19 for overall group comparisons.

[^4]: All values are in pg/mL and expressed as median (interquartile range, IQR).

[^5]: Significant differences are shown in italics.

[^6]: Allergen-specific IgE \> 0.35 kU/L for common allergens (Phadiatop Combi; Phadia, Uppsala, Sweden).
